OBJECTIVE:

Determine maternal and perinatal risk in women with aortic coarctation.

MATERIAL AND METHOD:

A study of cases and controls in women admitted in the period 2011- 2016 during antenatal care was performed. 13 cases were found. We calculated OR for maternal complications such as preeclampsia, bleeding, hypertension and proteinuria; fetal and intrauterine growth restriction, prematurity and Apgar.

RESULTS:

Maternal morbidity for postpartum hemorrhage was 5.7 (p=0.2), OR 3.8 (CI 95% 0.31-46.9), 11.4 preeclampsia (p=0.1), OR 4.4 (CI 95% 0.6-28.8), 14.3 hypertension (p=0.35), OR 2.8 (CI 95% 0.59-3.13), proteinuria, 14.4 (p=0.09) OR 3.9 (CI 95% 0.75- 20). Growth restriction 8.6 (p=0.09), OR 6.3 (CI 95% 0.5- 68.4). Gestational age of 35.1 ± 6.1 SDG interruption (p=0.05), with 27% (6 of 13 cases) with prematurity and 27.7% (6 of 22 controls), no statistical differences in the Apgar score.

CONCLUSION:

Pregnant women who present with coarctation of the aorta, there is an increase in morbidity as has been demonstrated in previous publications; however, the main limitation of the study is the low number of cases and requires further research.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )